Encapsulating peritoneal sclerosis in liver transplant
DOI:
https://doi.org/10.4322/acr.2021.272Keywords:
Peritoneal Disease, Liver Transplantation, Intestinal ObstructionAbstract
Encapsulating peritoneal sclerosis occurs due to chronic irritation of the peritoneal surface resulting in inflammation and fibrosis. Encapsulating peritoneal sclerosis usually occurs in patients requiring peritoneal dialysis (PD); however, it may also occur in liver transplant patients. The fibrosis in encapsulating peritoneal sclerosis could be severe enough to cause small bowel obstruction (SBO). Herein, we report a case of encapsulating peritoneal sclerosis secondary to liver transplantation that presented with SBO. The patient was started on Tamoxifen for encapsulating peritoneal sclerosis and evaluated at follow-up without any other intestinal obstruction episodes. This case demonstrates that encapsulating peritoneal sclerosis can occur as a liver transplant complication and present with small bowel obstruction.
Downloads
References
Cohen O, Abrahamson J, Ben-Ari J, Frajewicky V, Eldar S. Sclerosing encapsulating peritonitis. J Clin Gastroenterol. 1996;22(1):54-7. http://dx.doi.org/10.1097/00004836-199601000-00016. PMid:8776099.
Kawaguchi Y, Kwanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. Perit Dial Int. 2000;20(Suppl 4):S43-55. http://dx.doi.org/10.1177/089686080002004S04. PMid:11098928.
Kawanishi H, Kawaguchi Y. Prevalence and therapeutic outcome of sclerosing encapsulatingperitonitis: A multicenter study in Japan. Jin To Toseki. 2000;49:225-8. In Japanese.
Mekeel K, Moss A, Reddy KS, Douglas D, Mulligan D. Sclerosing peritonitis and mortality after liver transplantation. Liver Transpl. 2009;15(4):435-9. http://dx.doi.org/10.1002/lt.21702. PMid:19326414.
Maguire D, Srinivasan P, O’Grady J, Rela M, Heaton ND. Sclerosing encapsulating peritonitis after orthotopic liver transplantation. Am J Surg. 2001;182(2):151-4. http://dx.doi.org/10.1016/S0002-9610(01)00685-7. PMid:11574087.
van Bommel EF, Hendriksz TF, Huiskes AW, Zeegers AG. Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med. 2006;144(2):101-6. http://dx.doi.org/10.7326/0003-4819-144-2-200601170-00007. PMid:16418409.
Korte MR, Yo M, Betjes MG, et al. Increasing incidenceof sever encapsulating peritoneal sclerosis after kidney transplantation. Nephrol Dial Transplant. 2007;22(8):2412-4. http://dx.doi.org/10.1093/ndt/gfm171. PMid:17395649.
Korte MR, Fieren MW, Sampimon DE, Lingsma HF, Weimar W, Betjes MGHR. Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study. Nephrol Dial Transplant. 2011;26(2):691-7. http://dx.doi.org/10.1093/ndt/gfq362.
Balasubramaniam G, Brown EA, Davenport A, et al. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2009;24(10):3209-15. http://dx.doi.org/10.1093/ndt/gfp008. PMid:19211652.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Autopsy and Case Reports
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
Authors of articles published by Autopsy and Case Report retain the copyright of their work without restrictions, licensing it under the Creative Commons Attribution License - CC-BY, which allows articles to be re-used and re-distributed without restriction, as long as the original work is correctly cited.
